AAAAAA

   
Results: 1-11 |
Results: 11
TACROLIMUS FOR STEROID-RESISTANT AND OKT3-RESISTANT REJECTION IN KIDNEY RECIPIENTS
Authors: KLIEM V PETERSEN R EHLERDING G SCHAUMANN D EISENBERGER U KOCH KM PICHLMAYR R BRUNKHORST R
Citation: V. Kliem et al., TACROLIMUS FOR STEROID-RESISTANT AND OKT3-RESISTANT REJECTION IN KIDNEY RECIPIENTS, Transplantation proceedings, 30(4), 1998, pp. 1251-1253
INTRAVENOUS PULSE ADMINISTRATION OF CYCLOPHOSPHAMIDE VERSUS DAILY ORAL TREATMENT IN PATIENTS WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS AND RENAL INVOLVEMENT - A PROSPECTIVE, RANDOMIZED STUDY
Authors: HAUBITZ M SCHELLONG S GOBEL U SCHUREK HJ SCHAUMANN D KOCH KM BRUNKHORST R
Citation: M. Haubitz et al., INTRAVENOUS PULSE ADMINISTRATION OF CYCLOPHOSPHAMIDE VERSUS DAILY ORAL TREATMENT IN PATIENTS WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS AND RENAL INVOLVEMENT - A PROSPECTIVE, RANDOMIZED STUDY, Arthritis and rheumatism, 41(10), 1998, pp. 1835-1844
LONG-TERM RESULTS AFTER PRIMARY SUCCESSFUL FK-506 TREATMENT OF STEROID-RESISTANT AND OKT3-RESISTANT REJECTION IN RENAL-TRANSPLANT RECIPIENTS
Authors: KLIEM V SCHAUMANN D EHLERDING G EBERHARD OK LUFFT V SCHLITT HJ PICHLMAYR R KOCH KM BRUNKHORST R
Citation: V. Kliem et al., LONG-TERM RESULTS AFTER PRIMARY SUCCESSFUL FK-506 TREATMENT OF STEROID-RESISTANT AND OKT3-RESISTANT REJECTION IN RENAL-TRANSPLANT RECIPIENTS, Transplantation proceedings, 29(7), 1997, pp. 2955-2957
SUCCESSFUL THERAPY OF CHRONIC RENAL-ALLOGRAFT REJECTION BY ENHANCED IMMUNOSUPPRESSION
Authors: EHLERDING G KLIEM V TIROKE T EBERHARD O SCHAUMANN D PICHLMAYR R KOCH KM BRUNKHORST R
Citation: G. Ehlerding et al., SUCCESSFUL THERAPY OF CHRONIC RENAL-ALLOGRAFT REJECTION BY ENHANCED IMMUNOSUPPRESSION, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3300-3300
CONVERSION FROM FK-506 TO CYCLOSPORINE-A (CSA) BECAUSE OF FK 506-ASSOCIATED ADVERSE-EFFECTS IN KIDNEY-TRANSPLANTATION IS EFFECTIVE AND SAFE
Authors: SCHAUMANN D KLEIN V EHLERDING G BEHREND M SCHLITT HJ PICHLMAYR R KOCH KM BRUNKHORST R
Citation: D. Schaumann et al., CONVERSION FROM FK-506 TO CYCLOSPORINE-A (CSA) BECAUSE OF FK 506-ASSOCIATED ADVERSE-EFFECTS IN KIDNEY-TRANSPLANTATION IS EFFECTIVE AND SAFE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3465-3465
FK-506 IN THE TREATMENT OF STEROID-RESISTANT AND OKT3-RESISTANT REJECTION IN RENAL-TRANSPLANT RECIPIENTS - REDUCED DOSAGE AND ANTIINFECTIVEPROPHYLAXIS
Authors: KLIEM V EBERHARD OK OLDHAFER K SCHLITT HJ BEHREND M SCHAUMANN D PICHLMAYR R KOCH KM BRUNKHORST R
Citation: V. Kliem et al., FK-506 IN THE TREATMENT OF STEROID-RESISTANT AND OKT3-RESISTANT REJECTION IN RENAL-TRANSPLANT RECIPIENTS - REDUCED DOSAGE AND ANTIINFECTIVEPROPHYLAXIS, Transplantation proceedings, 28(6), 1996, pp. 3166-3168
PROSPECTIVE CROSS-OVER COMPARISONS OF 3 LOW-DENSITY-LIPOPROTEIN (LDL)-APHERESIS METHODS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
Authors: SCHAUMANN D WELCHWICHARY M VOSS A SCHMIDT H OLBRICHT CJ
Citation: D. Schaumann et al., PROSPECTIVE CROSS-OVER COMPARISONS OF 3 LOW-DENSITY-LIPOPROTEIN (LDL)-APHERESIS METHODS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, European journal of clinical investigation, 26(11), 1996, pp. 1033-1038
LUMBAR SPONDYLODISCITIS BECAUSE OF SALMON ELLA-ENTERITIDIS
Authors: SCHULER A SCHAUMANN D MANNS MP KOCH KM
Citation: A. Schuler et al., LUMBAR SPONDYLODISCITIS BECAUSE OF SALMON ELLA-ENTERITIDIS, Deutsche Medizinische Wochenschrift, 119(41), 1994, pp. 1383-1387
SHORT-TERM CYCLOPHOSPHAMIDE (CP) BOLUS THERAPY FOR LUPUS NEPHRITIS
Authors: SCHAUMANN D HEIN R NEUMANN KH BRUNKHORST R SCHMIDT RE KOCH KM
Citation: D. Schaumann et al., SHORT-TERM CYCLOPHOSPHAMIDE (CP) BOLUS THERAPY FOR LUPUS NEPHRITIS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 360-360
PULSE CYCLOPHOSPHAMIDE TREATMENT OF LUPUS NEPHRITIS
Authors: WITTE T SCHAUMANN D HEIN R HELMCHEN U NEUMANN KH KOCH KM DEICHER H SCHMIDT RE
Citation: T. Witte et al., PULSE CYCLOPHOSPHAMIDE TREATMENT OF LUPUS NEPHRITIS, Deutsche Medizinische Wochenschrift, 118(27-28), 1993, pp. 1005-1010
INTRAVENOUS CYCLOPHOSPHAMIDE (CP) PULSE THERAPY FOR LUPUS NEPHRITIS -DURATION OF INDUCTION THERAPY
Authors: SCHAUMANN D HEIN R WITTE T SCHMIDT RE BRUNKHORST R NEUMANN KH DEICHER H KOCH KM
Citation: D. Schaumann et al., INTRAVENOUS CYCLOPHOSPHAMIDE (CP) PULSE THERAPY FOR LUPUS NEPHRITIS -DURATION OF INDUCTION THERAPY, Kidney international, 44(1), 1993, pp. 249-249
Risultati: 1-11 |